We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KRUS:NASDAQKura Sushi USA, Inc. Analysis

Data as of 2026-05-25 - not real-time

$54.28

Latest Price

8/10Risk

Risk Level: High

Executive Summary

KRUS is trading at $54.28, just above its 20‑day SMA of $53.92 but well below the 50‑day ($58.57) and 200‑day ($63.12) averages, indicating short‑term momentum yet a longer‑term bearish bias. The price sits near the calculated support of $47.82 and faces resistance around $58.66, while the RSI of 47 suggests neutral pressure and the MACD histogram’s positive 0.43 points to a fleeting bullish signal. However, volatility is extreme at 55% over the past 30 days and a beta above 1.1 signals heightened sensitivity to market swings, reinforced by a Fear & Greed Index reading of “Extreme Greed.”
Fundamentally, the company posted 23% revenue growth but continues to operate with thin gross margins (16%) and negative operating and profit margins, resulting in a trailing EPS of –$0.15 and a forward EPS of $0.28. Cash flow is strained, with $48 M of cash offset by $203 M of debt (debt‑to‑equity 88.8%) and negative free cash flow, while the DCF fair value of $33.74 implies the market price is roughly 47% above intrinsic value. Analyst consensus remains a “Buy” with a median target near $80, buoyed by a high‑profile Trump investment that sparked a short‑term rally, but the underlying financial weakness and overvaluation raise concerns for longer horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near short‑term support with modest bullish MACD signal
  • increased trading volume and Trump‑related news catalyst
  • high volatility and beta indicating rapid price swings

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • strong revenue growth but persistent negative margins
  • elevated debt load and negative free cash flow
  • valuation gap between market price and DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • overvaluation relative to intrinsic DCF estimate
  • structural profitability challenges and high leverage
  • consumer‑cyclical exposure to economic downturns

Key Metrics & Analysis

Financial Health

Revenue Growth23.30%
Profit Margin-0.63%
P/E Ratio192.0
ROE-0.85%
ROA-0.42%
Debt/Equity88.79
P/B Ratio2.9
Op. Cash Flow$24.2M
Free Cash Flow$-36375124

Technical Analysis

TrendBearish
RSI47.4
Support$47.82
Resistance$58.66
MA 20$53.92
MA 50$58.57
MA 200$63.12
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$33.74
Target Price$79.90
Upside/Downside47.20%
GradeOvervalued
TypeBlend

Risk Assessment

Beta1.16
Volatility55.43%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.